RYTHM, Inc. Reports Second Quarter 2026 Results

RYTHM, Inc. delivered a sharp revenue and profit surge, but faces looming regulatory risk.

What the company is saying

RYTHM, Inc. frames its second quarter as a period of rapid financial acceleration, highlighting a 73% sequential revenue jump to $23.0 million and a swing to $1.2 million in net income. The company emphasizes operational momentum, citing record THC beverage depletions of 25,000 cases in June 2026 across 18 states, and the start of a $70 million annual licensing fee from Green Thumb Industries Inc. Management presents these results as evidence of strong execution, with adjusted EBITDA rising to $6.4 million from breakeven. The announcement foregrounds cash generation, noting a $41.9 million cash balance and $8.7 million in operating cash flow. While the tone is confident and data-driven, the company explicitly withholds forward guidance due to regulatory uncertainty, signaling caution about the near-term outlook. The language is factual, with little promotional spin, and the absence of guidance is directly attributed to pending federal law changes.

What the data suggests

The reported numbers confirm a dramatic improvement in financial performance: revenue from continuing operations reached $23.0 million, up 73% from $13.3 million in the prior quarter. Net income turned positive at $1.2 million, and adjusted EBITDA climbed to $6.4 million. Cash increased to $41.9 million, supported by $8.7 million in cash flow from operations. Gross profit for the quarter was $18.5 million on $4.5 million in cost of goods sold, with operating expenses of $16.6 million. The balance sheet shows $135.4 million in total assets and $39.1 million in equity. THC beverage depletions more than tripled year-over-year in June, from 7,000 to 25,000 cases. The $70 million annual licensing fee from Green Thumb Industries Inc. is already in effect, providing a recurring revenue stream. The only less verifiable metric is the 67% sequential increase in hemp-derived product revenue, which lacks a disclosed dollar amount. Overall, the data is transparent for core financials, with realised gains and no evidence of aggressive accounting or narrative inflation.

Analysis

The announcement's tone is positive but proportionate to the substantial, realised financial progress disclosed. Nearly all key claims are supported by detailed, current-period numerical data, including revenue, net income, adjusted EBITDA, and cash flow from operations. The only forward-looking statement is the absence of guidance due to regulatory uncertainty, which is a conservative disclosure rather than promotional hype. The $70 million annual licensing fee is already in effect, not merely projected. There is no evidence of narrative inflation or overstatement; the language is factual and closely tied to realised results. No large capital outlay is paired with long-dated, uncertain returns, and the benefits of recent agreements are already being realised.

Risk flags

• ●Regulatory risk is acute: forthcoming changes in federal law affecting hemp-derived THC products are scheduled for November 12, 2026. The company has suspended guidance for the next quarter, indicating that a material portion of revenue may be at risk if new regulations are unfavorable.
• ●Customer concentration risk is implied by the $70 million annual licensing fee from Green Thumb Industries Inc. If this agreement is interrupted or renegotiated, a large share of revenue could be lost, as no other comparable licensing streams are disclosed.
• ●Disclosure risk exists for segment-level performance: while overall financials are detailed, the 67% sequential increase in hemp-derived product revenue is not backed by specific dollar figures, limiting transparency into the contribution and volatility of this segment.

Bottom line

RYTHM, Inc. has delivered a quarter of exceptional realised growth, with revenue, net income, and cash flow all sharply higher and a major licensing agreement now contributing. The operational and financial data are robust, with nearly all key metrics disclosed and supported. The company’s decision to suspend forward guidance is a direct response to imminent regulatory changes, making future performance highly sensitive to federal law outcomes. The $70 million licensing fee provides near-term stability, but heavy reliance on a single agreement and the regulatory environment introduces material risk. Investors should treat current results as a snapshot of realised momentum, not a guarantee of future performance. The most important takeaway is that while the business is firing on all cylinders today, the sustainability of these gains depends almost entirely on external regulatory developments in the coming months.

Announcement summary

(NASDAQ: RYM) RYTHM, Inc. announced financial results for the second quarter ended June 30, 2026, reporting revenue from continuing operations of $23.0 million, up 73% from $13.3 million in the prior quarter. Cash increased to $41.9 million, driven by cash flow from operations of $8.7 million, and net income was $1.2 million. Adjusted EBITDA for the quarter was $6.4 million compared to approximately breakeven in the prior quarter. Fixed annual cash licensing fees of $70 million from Green Thumb Industries Inc. took effect April 1, 2026. THC beverage depletions increased to approximately 25,000 cases across 18 states in June 2026, compared to approximately 7,000 in June 2025. Due to uncertainty stemming from forthcoming changes in federal law affecting hemp-derived THC products, scheduled to take effect November 12, 2026, the Company is not providing an outlook for the third quarter of 2026 at this time.

Disagree with this article?